Sleep + Recovery Stack
Goal · Sleep-architecture support plus endogenous GH-pulse research.
DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide originally isolated from rabbit cerebral venous blood during electrically induced sleep states. Russian preclinical literature describes delta-wave EEG modulation and HPA-axis stress dampening. Sermorelin is the native GHRH(1-29) sequence, formerly FDA-approved as Geref for pediatric GHD, that triggers endogenous GH release with a pulse that follows the natural pulsatile rhythm. The two are paired in research framings because the natural largest GH pulse occurs during slow-wave sleep; supporting slow-wave architecture with DSIP while simultaneously providing GHRH-axis stimulation with sermorelin is theoretically synergistic with the natural physiology.
COMPONENTS
Delta-wave EEG modulation · slow-wave sleep architecture
GHRH(1-29) pulse-rhythm-aligned endogenous GH release
CYCLE FRAMING
Variable · Russian preclinical and community-reported research protocols describe 2-8 week courses
RESEARCH NOTE
Both compounds have limited Western RCT evidence in this specific combination. Per-component mechanisms support the framing; no published RCT validates the stack. Sermorelin is WADA-prohibited under Section S2.
SOURCED FROM PEPPU LABS
Each component is available individually as research-grade material at Peppu Studio · ≥99% purity · per-batch CoA. For laboratory research use only. No human dose is recommended.